Epigenetic alterations at diagnosis predict susceptibility, prognosis and treatment escalation in inflammatory bowel disease - IBD Character

MLA

Adams, A., et al. Epigenetic Alterations at Diagnosis Predict Susceptibility, Prognosis and Treatment Escalation in Inflammatory Bowel Disease - IBD Character. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234107340&authtype=sso&custid=ns315887.

APA

Adams, A., Kalla, R., Vatn, S., Bonfiglio, F., Nimmo, E., Kennedy, N., Ventham, N., Vatn, M., Ricanek, P., Bergemalm, D., Halfvarson, J., Söderholm, J., Pierik, M., Törkvist, L., Gomollon, F., Gut, I., Jahnsen, J., & Satsangi, J. (2017). Epigenetic alterations at diagnosis predict susceptibility, prognosis and treatment escalation in inflammatory bowel disease - IBD Character.

Chicago

Adams, A., R. Kalla, S. Vatn, F. Bonfiglio, E. Nimmo, N. Kennedy, N. Ventham, et al. 2017. “Epigenetic Alterations at Diagnosis Predict Susceptibility, Prognosis and Treatment Escalation in Inflammatory Bowel Disease - IBD Character.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234107340&authtype=sso&custid=ns315887.